Aeglea Biotherapeutics (NASDAQ:AGLE)

Aeglea Biotherapeutics (NASDAQ:AGLE)

Share Price
$ 7.09
-0.06 (-0.84 %)
Market Cap
$204.82 m
Proactive Investors - Run By Investors For Investors

Aeglea Biotherapeutics

Discovery and Innovation

As a leader in creating and developing novel engineered human enzymes to degrade specific amino acids in the blood, we are focused on providing safe and effective products to patients.

What does success mean to us? It means…

. Unlocking the potential therapeutic value of engineered human enzymes while avoiding immune responses
. Meeting serious unmet...

52-week High/Low: $11.160 / $5.990
Sector: Aerospace
Market Cap: $204.82 m
col 3
col 4
col 5
col 6

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use